|
PHKB expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.74590391827701E-11 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.05270014927328E-10 |
| Normal-vs-Stage2 |
1.244550E-03 |
| Normal-vs-Stage3 |
3.391800E-04 |
| Normal-vs-Stage4 |
8.98940000215731E-08 |
| Stage1-vs-Stage2 |
7.658400E-01 |
| Stage1-vs-Stage3 |
6.252200E-01 |
| Stage1-vs-Stage4 |
3.543600E-01 |
| Stage2-vs-Stage3 |
9.162400E-01 |
| Stage2-vs-Stage4 |
2.854600E-01 |
| Stage3-vs-Stage4 |
2.420800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.68830554775946E-11 |
| Normal-vs-AfricanAmerican |
1.40540000004297E-06 |
| Normal-vs-Asian |
2.779400E-01 |
| Caucasian-vs-AfricanAmerican |
7.366400E-01 |
| Caucasian-vs-Asian |
6.244400E-01 |
| AfricanAmerican-vs-Asian |
7.413800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.20208312590375E-12 |
| Normal-vs-Female |
8.561600E-04 |
| Male-vs-Female |
1.033790E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.39650000003022E-06 |
| Normal-vs-Extreme_Weight |
5.02786701161995E-12 |
| Normal-vs-Obese |
3.2588999998584E-07 |
| Normal-vs-Extreme_Obese |
2.038100E-02 |
| Normal_Weight-vs-Extreme_Weight |
5.324600E-01 |
| Normal_Weight-vs-Obese |
4.914200E-01 |
| Normal_Weight-vs-Extreme_Obese |
9.424000E-01 |
| Extreme_Weight-vs-Obese |
8.687500E-02 |
| Extreme_Weight-vs-Extreme_Obese |
6.101600E-01 |
| Obese-vs-Extreme_Obese |
7.283000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.89410000004131E-06 |
| Normal-vs-Age(41-60Yrs) |
2.90720003626177E-09 |
| Normal-vs-Age(61-80Yrs) |
5.29799981663359E-10 |
| Normal-vs-Age(81-100Yrs) |
2.661900E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.343800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.306000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.701200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.069000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.240200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.072200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
4.24438262314197E-13 |
| Normal-VS-Type2 PRCC |
4.15220000000716E-05 |
| Normal-VS-KIRP CIMP |
7.006900E-04 |
| Normal-VS-Unclassified PRCC |
4.875700E-02 |
| Type1 PRCC-VS-Type2 PRCC |
3.652100E-02 |
| Type1 PRCC-VS-KIRP CIMP |
3.934200E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
2.313800E-02 |
| Type2 PRCC-VS-KIRP CIMP |
7.971200E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
3.672600E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
4.614800E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.92609999955162E-07 |
| Normal-vs-N1 |
1.55400000001471E-06 |
| Normal-vs-N2 |
5.78409999999474E-05 |
| N0-vs-N1 |
9.164400E-01 |
| N0-vs-N2 |
4.677600E-01 |
| N1-vs-N2 |
3.177200E-01 |
|
|
